Skip to main content

Table 6 Modified Rankin Scale (MRS) among patients group

From: Paradoxical role of hepatocyte growth factor in ischemic stroke: stroke risk/stroke recovery

  The patient group (100 stroke patients) Test P value
Carotid atherosclerosis N = 50 Cardioembolic N = 50 Total N = 100
No % No % X2
MRS
 0 5 10 0 0 5 5 77.2 < 0.001*
 1 10 20 2 4 12 12
 2 12 24 1 2 13 13
 3 8 16 3 6 11 11
 4 15 30 1 2 16 16
 5 0 0 39 78 39 39
 6 0 0 4 8 4 4
  1. X2 Chi-square test, MRS Modified Rankin Scale, *highly significant